Ranger Investment Management’s BioTelemetry, Inc. BEAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-484,403
Closed -$34.9M 118
2020
Q4
$34.9M Sell
484,403
-16,611
-3% -$870K 1.84% 25
2020
Q3
$22.8M Sell
501,014
-4,285
-0.8% -$179K 1.45% 30
2020
Q2
$22.8M Sell
505,299
-101,425
-17% -$4.54M 1.56% 27
2020
Q1
$23.4M Sell
606,724
-17,910
-3% -$825K 2.06% 20
2019
Q4
$28.9M Buy
624,634
+57,757
+10% +$2.5M 1.91% 22
2019
Q3
$23.1M Buy
566,877
+186,349
+49% +$8.05M 1.66% 26
2019
Q2
$18.3M Sell
380,528
-4,135
-1% -$217K 1.25% 38
2019
Q1
$24.1M Sell
384,663
-99,817
-21% -$6.86M 1.74% 23
2018
Q4
$28.9M Sell
484,480
-7,548
-2% -$453K 2.36% 14
2018
Q3
$31.7M Buy
492,028
+91,649
+23% +$5.11M 2.09% 19
2018
Q2
$18M Buy
+400,379
New +$16M 1.26% 39

Other funds holding BEAT

Ranger Investment Management's BEAT Position: Q1 2021 in Review

Ranger Investment Management sold out of BioTelemetry, Inc. (BEAT) in Q1 2021, closing a stake of 484,403 shares — an estimated $34.9M sold.

Ranger Investment Management first reported a position in BEAT in Q2 2018 and held it in 11 quarters. The position peaked at $34.9M in Q4 2020. 1 fund tracked by Wall St. Rank holds BEAT as of Q1 2021.

  • Ranger Investment Management reported no remaining BioTelemetry, Inc. position as of Q1 2021 after selling out during the quarter.
  • Ranger Investment Management sold 484,403 BioTelemetry, Inc. shares in Q1 2021, an estimated $34.9M.
  • Ranger Investment Management first reported a position in BioTelemetry, Inc. in Q2 2018 and held it in 11 quarters.
  • Ranger Investment Management's BioTelemetry, Inc. position peaked at $34.9M in Q4 2020.
  • 1 fund tracked by Wall St. Rank held BioTelemetry, Inc. as of Q1 2021.

Based on Ranger Investment Management's 13F filing for Q1 2021, filed 17 May 2021.